New York State Dormitory Authority, New York University Of Rochester; Joint Criteria; Private Coll/Univ - General Obligation Jun 09

  • ID: 1951836
  • June 2009
  • Region: New York
  • Standard & Poors
1 of 3


  • New York State Dorm Auth
  • Univ of Rochester
  • MORE

Standard & Poor's Ratings Services assigned its 'A+' long-term rating to New York State Dormitory Authority's series 2009 revenue bonds, issued for the University of Rochester. At the same time, Standard & Poor's affirmed its 'A+' SPURs and long-term rating on the university's previously issued bonds. The university will issue the series 2009 bonds in a fixed-rate mode with a final maturity date of July 1, 2039. The issuance will consist of four tranches the series 2009A, 2009B, 2009C, and 2009D for a par amount of approximately $140 million, including issuance costs. The university issued series 2009A and 2009C bonds as new debt totaling approximately $100 million. The series 2009B and 2009D bonds will be issued to refinance existing debt...

Companies mentioned in this report are:
- Univ of Rochester
- New York State Dorm Auth

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown
2 of 3

- Univ of Rochester
- New York State Dorm Auth

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.